Efficacy and safety of upadacitinib maintenance therapy in patients with moderately to severely active Crohn’s disease: 2-year results from the U-ENDURE Long-Term Extension studyEdward V. Loftus, Irina Blumenstein, Ana Paula Lacerda et al.|Journal of Crohn s and Colitis|2025Cited by 8
Upadacitinib Maintenance Therapy in Crohn’s Disease: Final Results From the Randomized Phase 3 U-ENDURE StudyRemo Panaccione, Julián Panés, Miguel Regueiro et al.|Clinical Gastroenterology and Hepatology|2025Cited by 4
947 EFFICACY AND SAFETY OF UPADACITINIB FOR THE TREATMENT OF FISTULAS AND FISSURES IN PATIENTS WITH CROHN'S DISEASEJean‐Frédéric Colombel, Walter Reinisch, Peter M. Irving et al.|Gastroenterology|2023Cited by 2
Su1798 UPADACITINIB TREATMENT IS ASSOCIATED WITH IMPROVED CLINICAL AND QUALITY OF LIFE OUTCOMES IN PATIENTS WITH CROHN'S DISEASE: RESULTS FROM THE U-ENDURE LONG-TERM EXTENSIONDavid T. Rubin, Peter Bossuyt, Édouard Louis et al.|Gastroenterology|2024Cited by 0